Auto Disable Syringes Market Report 2026

The auto disable syringes market size has grown rapidly in recent years. It will grow from $18.11 billion in 2025 to $21.34 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to increasing prevalence of bloodborne infections due to unsafe injection practices, rising global vaccination campaigns and immunization coverage, growing awareness regarding needle-stick injury prevention, expanding healthcare infrastructure in emerging economies, increasing regulatory mandates for single-use medical devices.

The auto disable syringes market size is expected to see rapid growth in the next few years. It will grow to $41.48 billion by 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to growing adoption of advanced safety-engineered syringe technologies, rising investments in automated medical device manufacturing facilities, increasing demand for infection control products in outpatient care settings, expanding public healthcare spending on vaccination programs, growing focus on sustainable and recyclable medical consumables. Major trends in the forecast period include increasing adoption of single-use safety injection devices in immunization programs, growing demand for low dead space auto-disable syringes for efficient drug delivery, rising implementation of infection prevention protocols in healthcare facilities, increasing government initiatives promoting safe injection practices in developing countries, growing preference for retractable and tamper-proof syringe mechanisms in clinical settings.

The rising prevalence of bloodborne diseases is expected to propel the growth of the auto-disable syringes market going forward. Bloodborne diseases are infectious conditions caused by pathogens transmitted through exposure to infected blood or blood-contaminated bodily fluids. The increase in bloodborne diseases is primarily driven by continued transmission among at-risk populations, including through unsafe or unscreened needle use and insufficient preventive measures in certain healthcare settings. Auto-disable syringes lock after a single use, preventing reuse and thereby reducing the transmission of bloodborne diseases by ensuring every injection remains safe and sterile. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based government agency responsible for protecting public health and safety through disease control and prevention, the number of acute hepatitis C cases rose from 4,848 in 2022 to 4,966 in 2023, reflecting an increase of 118 cases. Therefore, the rising prevalence of bloodborne diseases is contributing to and propelling the growth of the auto-disable syringe market.

Leading companies operating in the auto-disable syringe market are focusing on achieving global certifications and developing advanced safety-engineered injection devices to enhance patient safety, prevent reuse, and reduce the transmission of bloodborne infections. Safety-engineered injection devices are injection tools equipped with protective features that reduce needlestick injuries and promote safe use and disposal. For example, in September 2023, Revital Healthcare, a Kenya-based manufacturer of medical disposable products, achieved World Health Organization (WHO) prequalification for its early activation auto-disable syringe. This milestone validates the syringe’s compliance with international quality, safety, and performance standards, ensuring reliable prevention of reuse and supporting safe immunization practices across global healthcare systems.

In November 2023, Marubeni Corporation, a Japan-based trading and investment company, acquired a stake in PT One-ject Indonesia for an undisclosed amount. Through this acquisition, Marubeni seeks to strengthen its position in the medical consumables market by utilizing PT One-ject Indonesia’s robust manufacturing expertise in auto-disable syringes and other disposable medical devices, thereby supporting safer injection practices and the growing demand for infection prevention products. PT One-ject Indonesia is an Indonesia-based manufacturer specializing in medical consumables, including auto-disable syringes used in immunization and public health programs.

Major companies operating in the auto disable syringes market are Becton Dickinson and Company, B Braun Melsungen SE, Terumo Corporation, Nipro Corporation, ICU Medical Inc, Sol Millennium Medical Group Inc, Vogt Medical Vertrieb GmbH, Weigao Group Co Ltd, Retractable Technologies Inc, Shandong Sinorgmed Co Ltd, Jiangsu Jichun Medical Devices Co Ltd, Hindustan Syringes and Medical Devices Limited, Roma Medical Aids Private Limited, HLL Lifecare Limited, Numedico Technologies Private Limited, Star Syringe Limited, JMI Syringes and Medical Devices Limited, Zhejiang KangKang Medical Devices Co Ltd, PT Oneject Indonesia, Anhui Tiankang Medical Technology Co Ltd, Shanghai Kindly Enterprise Development Group Co Ltd.

North America was the largest region in the auto-disable syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the auto disable syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the auto disable syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The auto-disable syringes market consists of sales of fixed dose auto disable syringes, prefilled auto disable syringes, immunization auto disable syringes, and low dead space auto disable syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.